Wholesale Price Nafarelin Acetate Supplier - Degarelix acetate – JYMed
Wholesale Price Nafarelin Acetate Supplier - Degarelix acetate – JYMed Detail:
Keywords
- Degarelix
- most affordable price
- CAS# 214766-78-6
Quick Details
- ProName: Degarelix acetate
- CasNo:214766-78-6
- Molecular Formula: C82H103ClN18O16
- Appearance: white powder
- Application: Fields of Application： Advanced hormo…
- DeliveryTime: prompt shipment
- PackAge: according to customer’s requirements
- Port: Shenzhen
- ProductionCapacity: 2 Kilogram/Month
- Purity: 98%
- Storage: 2~8℃. protected from light
- Transportation: by air
- LimitNum: 1 Gram
Superiority
professional degarelix manufacturer in china.
high quality with gmp grade
large scale with competitive price
our products include: generic bulk peptide apis, cosmetic peptide, custom peptides and veterinary peptides.
Details
Molecular Formula：
C82H103ClN18O16
Relative Molecular Mass：
1632.28 g/mol
CAS-Number：
214766-78-6 (net)
Long-term Storage：
-20 ± 15°C
Synonym：
FE200486
Sequence：
Ac-D-2-Nal-D-4-Cpa-D-3-Pal-Ser-4-amino-Phe(L-hydroorotyl)-4-ureido-
D-Phe-Leu-Lys(isopropyl)-Pro-D-Ala-NH2 acetate salt
Fields of Application：
Advanced hormone-dependent prostate carcinoma
Active Substance：
Degarelix Acetate is an LHRH (GnRH) receptor antagonist, indicated for patients with advanced prostate cancer. Degarelix reversibly and dose-dependently suppresses gonadotropin and sex steroid levels by inhibiting the binding of endogenous LHRH to its receptors.
Degarelix showed to be at least as effective as leuprolide in sustaining levels of testosterone that are equivalent to or lower than that seen with castration.
Company Profile:
company name:Shenzhen JYMed Technology Co.,Ltd.
Year Established:2009
Capital: 89.5 Million RMB
Main product: Oxytocin Acetate,Vasopressin Acetate,Desmopressin Acetate,Terlipressin acetate, Caspofungin acetate, Micafungin sodium, Eptifibatide acetate, Bivalirudin TFA, Deslorelin Acetate,Glucagon Acetate,Histrelin Acetate,Liraglutide Acetate,Linaclotide Aceteate ,Degarelix Acetate,Buserelin Acetate,Cetrorelix Acetate,Goserelin
Acetate, Argireline Acetate, Metrixyl Acetate,Snap-8,…..
We strive for continuing innovations in new peptide synthesis technology and process optimization, and our technical team have over decade of experience in peptide synthesis.JYM has successfully submitted a lot
of ANDA peptide APIs and formulated products with CFDA and have more than fourty patents approved.
Our peptide plant is located in Nanjing, Jiangsu province and it has set up a facility of 30,000 square meters in compliance with cGMP guideline. The manufacture facility has been audited and inspected by both domestic and international clients.
With its excellent quality, most competitive price and strong technical support, JYM not only has gained recognitions for its products from Research organizations and Pharmaceutical industries, but also become one of the most reliable suppliers of peptides in China,. JYM is dedicated to be one of the world’s leading peptide provider in the near future.
Product detail pictures:
Related Product Guide:
A 30-Year History of PLG Applications in Parenteral Controlled Drug Release | Synthetic Angiotensin Ii Gmp Provider From China
Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells | Lanreotide
Our target is always to satisfy our customers by offering golden support, superior value and high quality for Wholesale Price Nafarelin Acetate Supplier - Degarelix acetate – JYMed, The product will supply to all over the world, such as: Johannesburg, Leicester, French, Our company, is always regarding quality as company' s foundation, seeking for development via high degree of credibility , abiding by iso9000 quality management standard strictly , creating top-ranking company by spirit of progress-marking honesty and optimism.
By Tony from Azerbaijan - 2015.09.21 11:01
This company can be well to meet our needs on product quantity and delivery time, so we always choose them when we have procurement requirements.
By Naomi from Guinea - 2016.03.07 13:42
